Page last updated: 2024-12-08

11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

## 11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH)

**11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH)** is a major metabolite of THC, the psychoactive compound in cannabis. It is formed in the liver by the process of metabolism.

**Importance in Research:**

* **Biomarker for cannabis use:** THCCOOH is a reliable indicator of cannabis use, even long after the THC has been eliminated from the body. This is because it has a much longer half-life than THC. It is frequently detected in urine drug tests and blood samples, even weeks after last use.
* **Understanding THC metabolism:** Studying THCCOOH helps researchers understand the metabolic pathways of THC in the body and its interactions with various enzymes and other biological processes.
* **Pharmacological activity:** While THCCOOH is not psychoactive like THC, it has been shown to possess some pharmacological activity. Research is ongoing to explore its potential therapeutic applications, particularly in areas like pain management and anti-inflammatory properties.
* **Legal and forensic implications:** Detection of THCCOOH in biological samples is crucial in forensic investigations and legal cases related to cannabis use. It provides concrete evidence of prior exposure to cannabis, even if THC levels are undetectable.

**Key characteristics of THCCOOH:**

* **Not psychoactive:** It does not induce the high associated with THC.
* **Long half-life:** It remains detectable in the body for an extended period.
* **Presence in various biological samples:** It can be found in urine, blood, and hair.

**In conclusion,** 11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid (THCCOOH) is a crucial compound for research, providing valuable insights into cannabis metabolism, forensic investigations, and potential therapeutic applications.

Cross-References

ID SourceID
PubMed CID162389
SCHEMBL ID7755376
MeSH IDM0054075

Synonyms (23)

Synonym
PDSP2_000216
delta(8)-thc-11-oic acid
39690-06-7
(6ar,10ar)-1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid
11-nor-delta(8)-thc-cooh
685zu7k3sy ,
delta(6)-tetrahydrocannabinol-7-oic acid
delta(8)-tetrahydrocannabinol-11-oic acid
11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid
11-nor-8-carboxy-thc
6h-dibenzo(b,d)pyran-9-carboxylic acid, 6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-, (6ar-trans)-
unii-685zu7k3sy
(6ar,10ar)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-6h-dibenzo[b,d]pyran-9-carboxylic acid
6h-dibenzo[b,d]pyran-9-carboxylicacid, 6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-pentyl-, (6ar,10ar)-
9-carboxy-11-nor-delta-8-tetrahydrocannabinol
9-carboxy-11-nor-8-delta-thc
9-carboxy-11-nor-.delta.-8-tetrahydrocannabinol
OGXXAQFMAFTSRU-HZPDHXFCSA-N
SCHEMBL7755376
Q27264222
1-hydroxy-6,6-dimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6h-dibenzo[b,d]pyran-9-carboxylic acid
DTXSID30960300
(?)-11-nor-9-carboxy-?8-thc
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (18.75)18.2507
2000's8 (50.00)29.6817
2010's5 (31.25)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies1 (5.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (85.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]